Golden-Mason L - Search Results

1

Control of HCV Infection by Natural Killer Cells and Macrophages.

Rosen HR, Golden-Mason L. Rosen HR, et al. Cold Spring Harb Perspect Med. 2020 Sep 1;10(9):a037101. doi: 10.1101/cshperspect.a037101. Cold Spring Harb Perspect Med. 2020. PMID: 31871225 Free PMC article. Review.

2

Revisiting the Paradox of Interferon-Stimulated Gene Expression as a Predictor of Hepatitis C Virus Treatment Response, a Decade Later.

Golden-Mason L, Rosen HR. Golden-Mason L, et al. Hepatology. 2018 Dec;68(6):2053-2055. doi: 10.1002/hep.30195. Epub 2018 Nov 13. Hepatology. 2018. PMID: 30055107 Free PMC article. No abstract available.

3

Dietary Lipids Differentially Shape Nonalcoholic Steatohepatitis Progression and the Transcriptome of Kupffer Cells and Infiltrating Macrophages.

McGettigan B, McMahan R, Orlicky D, Burchill M, Danhorn T, Francis P, Cheng LL, Golden-Mason L, Jakubzick CV, Rosen HR. McGettigan B, et al. Hepatology. 2019 Jul;70(1):67-83. doi: 10.1002/hep.30401. Epub 2019 Feb 27. Hepatology. 2019. PMID: 30516830 Free PMC article.

4

Phenotypic and functional changes of cytotoxic CD56pos natural T cells determine outcome of acute hepatitis C virus infection.

Golden-Mason L, Castelblanco N, O'Farrelly C, Rosen HR. Golden-Mason L, et al. J Virol. 2007 Sep;81(17):9292-8. doi: 10.1128/JVI.00834-07. Epub 2007 Jun 6. J Virol. 2007. PMID: 17553896 Free PMC article.

5

Mechanisms of Disease: HCV-induced liver injury.

Mengshol JA, Golden-Mason L, Rosen HR. Mengshol JA, et al. Nat Clin Pract Gastroenterol Hepatol. 2007 Nov;4(11):622-34. doi: 10.1038/ncpgasthep0961. Nat Clin Pract Gastroenterol Hepatol. 2007. PMID: 17978819 Review.

6

Pretransplantation CD56(+) innate lymphocyte populations associated with severity of hepatitis C virus recurrence.

Rosen HR, Doherty DG, Madrigal-Estebas L, O'Farrelly C, Golden-Mason L. Rosen HR, et al. Liver Transpl. 2008 Jan;14(1):31-40. doi: 10.1002/lt.21265. Liver Transpl. 2008. PMID: 18161829 Free article.

7

Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy.

Burton JR Jr, Klarquist J, Im K, Smyk-Pearson S, Golden-Mason L, Castelblanco N, Terrault N, Rosen HR; Virahep-C Study Group. Burton JR Jr, et al. J Hepatol. 2008 Sep;49(3):329-38. doi: 10.1016/j.jhep.2008.05.020. Epub 2008 Jun 23. J Hepatol. 2008. PMID: 18644644 Clinical Trial.

8

A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection.

Mengshol JA, Golden-Mason L, Arikawa T, Smith M, Niki T, McWilliams R, Randall JA, McMahan R, Zimmerman MA, Rangachari M, Dobrinskikh E, Busson P, Polyak SJ, Hirashima M, Rosen HR. Mengshol JA, et al. PLoS One. 2010 Mar 4;5(3):e9504. doi: 10.1371/journal.pone.0009504. PLoS One. 2010. PMID: 20209097 Free PMC article.

9

Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro.

Golden-Mason L, Cox AL, Randall JA, Cheng L, Rosen HR. Golden-Mason L, et al. Hepatology. 2010 Nov;52(5):1581-9. doi: 10.1002/hep.23896. Hepatology. 2010. PMID: 20812318 Free PMC article.

10

Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C.

Golden-Mason L, Bambha KM, Cheng L, Howell CD, Taylor MW, Clark PJ, Afdhal N, Rosen HR; Virahep-C Study Group. Golden-Mason L, et al. Hepatology. 2011 Nov;54(5):1559-69. doi: 10.1002/hep.24556. Epub 2011 Aug 24. Hepatology. 2011. PMID: 21983945 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters